雌激素受体-阴性乳腺癌的临床试验
总计11877个结果
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...University of Milan; European Institute of Oncology; IFOM, The FIRC Institute of Molecular Oncology主动,不招人
-
Fudan University主动,不招人
-
Arbeitsgemeinschaft medikamentoese TumortherapieTakeda终止
-
University Hospital TuebingenUniversity Hospital Freiburg; University Hospital Ulm招聘中
-
Fujian Cancer Hospital尚未招聘
-
Gilead SciencesParexel; IQVIA RDS (Shanghai) Co., Ltd.; Medidata Solutions; Q Squared Solutions (Beijing) Co., Ltd主动,不招人
-
University of Alabama at BirminghamGlaxoSmithKline; AbbVie; Breast Cancer Research Foundation of Alabama主动,不招人
-
Instituto Nacional de Cancer, BrazilDana-Farber Cancer Institute完全的三阴性乳腺癌患者
-
The Netherlands Cancer InstituteMaarten van de Weijden Foundation; AVL Foundation尚未招聘
-
AbbVie招聘中肝细胞癌 | 三阴性乳腺癌 | 胰腺导管腺癌 | 食管鳞状细胞癌 | 胆道癌 | 激素受体+/人表皮生长因子受体 2 阴性乳腺癌 | 头颈鳞状细胞癌美国, 以色列, 日本, 波多黎各, 大韩民国, 台湾
-
Gustave Roussy, Cancer Campus, Grand ParisAstraZeneca招聘中
-
Huihua Xiong招聘中
-
Wake Forest University Health SciencesMerck Sharp & Dohme LLC; G1 Therapeutics, Inc.招聘中
-
First Affiliated Hospital of Shantou University...Guangdong ProCapZoom Biosciences Co., Ltd.尚未招聘
-
Memorial Sloan Kettering Cancer CenterSynDevRx, Inc.招聘中
-
The First Affiliated Hospital with Nanjing Medical...尚未招聘
-
AstraZeneca主动,不招人转移性三阴性乳腺癌美国, 比利时, 意大利, 西班牙, 英国, 加拿大, 捷克语, 波兰, 法国, 大韩民国, 德国, 台湾, 葡萄牙, 荷兰, 爱尔兰
-
AHS Cancer Control AlbertaTom Baker Cancer Centre撤销
-
SOLTI Breast Cancer Research Group招聘中
-
George T. BuddUnited States Department of Defense; Anixa Biosciences, Inc.招聘中
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)招聘中
-
Eisai Co., Ltd.完全的
-
Sichuan Baili Pharmaceutical Co., Ltd.Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.尚未招聘
-
IFOM ETS - The AIRC Institute of Molecular OncologyAstraZeneca招聘中